Process intensification (PI) enhances the efficiency, flexibility, and sustainability of complex molecule manufacturing by reducing costs and increasing throughput. That is why the monoclonal antibody ...

Mark Perreault is Senior Director of Research & Development at Repligen Corp., a bioprocessing-focused life sciences company bringing expertise and innovation to customers since 1981. Mark earned his ...

ProteoNic 2G UNic® Technology Licensed by Ginkgo Bioworks for BARDA-Supported Consortium Advancing Monoclonal Antibody Manufacturing for Anti-Filovirus Therapies The project, with a total value of up ...